Acadia Healthcare has appointed Mike Fucci to its Board of Directors as an independent director, a move that expands the board to nine members, eight of whom are independent. The appointment, effective immediately, reinforces Acadia Healthcare’s focus on strengthening governance and talent strategy as the behavioral health provider executes its growth objectives.

Fucci retired in September 2020 after a distinguished career at Deloitte, where he served most recently as Chairman Emeritus of Deloitte U.S. and previously as Executive Chairman from 2015 to 2019. Over a tenure that began in 1992, he held senior leadership roles including Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and led the firm’s human capital and advisory teams. His corporate governance experience includes membership on both the Deloitte U.S. and Deloitte Global Boards of Directors, where he chaired and served on committees responsible for risk oversight, governance and executive compensation.

At Deloitte U.S., Fucci provided operational leadership on organization strategy, leadership succession, risk mitigation, talent development and executive performance and compensation. He also established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors focused on research, trends and board-level perspectives. In addition, Fucci chaired the Deloitte Foundation, overseeing the philanthropic organization’s education initiatives.

Acadia Healthcare’s leadership described the appointment as an important addition to the board given Fucci’s background in human resource transformation and corporate talent strategies, coupled with his experience in risk mitigation and regulatory oversight. Board chair Reeve B. Waud cited Fucci’s tenure as a principal and practitioner at Deloitte U.S. as particularly relevant to Acadia’s ongoing priorities, including governance, workforce development and long-term value creation for shareholders.

Fucci expressed readiness to support Acadia’s mission as a leading provider of behavioral healthcare services, noting the heightened demand for behavioral health care amid the COVID-19 pandemic and the company’s role in meeting those needs across multiple care settings.

Acadia Healthcare Company, Inc., listed on NASDAQ under the ticker ACHC, operates a broad network of behavioral healthcare facilities. As of June 30, 2020, the company reported a network of 589 behavioral healthcare facilities with approximately 18,200 beds across 40 states, the United Kingdom and Puerto Rico. Acadia delivers services in inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

The board addition of Mike Fucci follows a trend among healthcare companies to bolster governance with seasoned corporate leaders who can bring cross-industry experience in risk management, talent development and strategic planning. For Acadia Healthcare, Fucci’s appointment signals a continued emphasis on strengthening board expertise to navigate regulatory, operational and workforce challenges while advancing the company’s growth strategy.